BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 6225718)

  • 1. Activating proteins for ganglioside GM2 degradation by beta-hexosaminidase isoenzymes in tissue extracts from different species.
    Burg J; Banerjee A; Conzelmann E; Sandhoff K
    Hoppe Seylers Z Physiol Chem; 1983 Jul; 364(7):821-9. PubMed ID: 6225718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complexing of glycolipids and their transfer between membranes by the activator protein for degradation of lysosomal ganglioside GM2.
    Conzelmann E; Burg J; Stephan G; Sandhoff K
    Eur J Biochem; 1982 Apr; 123(2):455-64. PubMed ID: 6210531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of activating protein and surfactants with human liver hexosaminidase A and GM2 ganglioside.
    Hechtman P; Kachra Z
    Biochem J; 1980 Mar; 185(3):583-91. PubMed ID: 7387624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Substrate binding properties of the human liver hexosaminidase A activator protein.
    Hechtman P; Isaacs C; Smith-Jones L
    Can J Biochem Cell Biol; 1985 Aug; 63(8):830-8. PubMed ID: 2933135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for two different active sites on human beta-hexosaminidase A. Interaction of GM2 activator protein with beta-hexosaminidase A.
    Kytzia HJ; Sandhoff K
    J Biol Chem; 1985 Jun; 260(12):7568-72. PubMed ID: 3158659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deficiency of the hexosaminidase A activator protein in a case of GM2 gangliosidosis; variant AB.
    Hechtman P; Gordon BA; Ng Ying Kin NM
    Pediatr Res; 1982 Mar; 16(3):217-22. PubMed ID: 6801612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assay of ganglioside GM2-N-acetyl-beta-D-galactosaminidase activity in human fibroblasts employing the natural activator protein--diagnosis of variant forms of GM2 gangliosidosis.
    Erzberger A; Conzelmann E; Sandhoff K
    Clin Chim Acta; 1980 Dec; 108(3):361-8. PubMed ID: 6781795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Juvenile GM2 gangliosidosis (AMB variant): inability to activate hexosaminidase A by activator protein.
    Inui K; Grebner EE; Jackson LG; Wenger DA
    Am J Hum Genet; 1983 Jul; 35(4):551-64. PubMed ID: 6224417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The protein activator specific for the enzymic hydrolysis of GM2 ganglioside in normal human brain and brains of three types of GM2 gangliosidosis.
    Hirabayashi Y; Li YT; Li SC
    J Neurochem; 1983 Jan; 40(1):168-75. PubMed ID: 6848657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of an activating factor required for hydrolysis of Gm2 ganglioside catalyzed by hexosaminidase A.
    Hechtman P
    Can J Biochem; 1977 Apr; 55(4):315-24. PubMed ID: 858083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and specificity of human GM2 activator protein.
    Wu YY; Lockyer JM; Sugiyama E; Pavlova NV; Li YT; Li SC
    J Biol Chem; 1994 Jun; 269(23):16276-83. PubMed ID: 8206933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolation and characterization of an activator protein for the hydrolysis of ganglioside GM2 from the roe of striped mullet (Mugil cephalus).
    DeGasperi R; Li YT; Li SC
    Biochem J; 1989 Jun; 260(3):777-83. PubMed ID: 2527497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of modification of sialic acid on enzymic hydrolysis of gangliosides GM1 and GM2.
    Li SC; Serizawa S; Li YT; Nakamura K; Handa S
    J Biol Chem; 1984 May; 259(9):5409-10. PubMed ID: 6232275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Isolation and characteristics of hexosaminidase A and activator protein from human kidney].
    Aronovich EL; Akhunov VS; Krasnopol'skaia KD
    Biokhimiia; 1990 Jan; 55(1):43-51. PubMed ID: 2140519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The specificity of human N-acetyl-beta-D-hexosaminidases towards glycosphincolipids is determined by an activator protein.
    Conzelmann E; Sandhoff K
    Adv Exp Med Biol; 1980; 125():295-306. PubMed ID: 6444774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formation of a ternary complex between GM2 activator protein, GM2 ganglioside and hexosaminidase A.
    Yadao F; Hechtman P; Kaplan F
    Biochim Biophys Acta; 1997 Jun; 1340(1):45-52. PubMed ID: 9217013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activator protein required for the enzymatic hydrolysis of cerebroside sulfate. Deficiency in urine of patients affected with cerebroside sulfatase activator deficiency and identity with activators for the enzymatic hydrolysis of GM1 ganglioside and globotriaosylceramide.
    Li SC; Kihara H; Serizawa S; Li YT; Fluharty AL; Mayes JS; Shapiro LJ
    J Biol Chem; 1985 Feb; 260(3):1867-71. PubMed ID: 2981875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specificity of mouse GM2 activator protein and beta-N-acetylhexosaminidases A and B. Similarities and differences with their human counterparts in the catabolism of GM2.
    Yuziuk JA; Bertoni C; Beccari T; Orlacchio A; Wu YY; Li SC; Li YT
    J Biol Chem; 1998 Jan; 273(1):66-72. PubMed ID: 9417048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AB variant of infantile GM2 gangliosidosis: deficiency of a factor necessary for stimulation of hexosaminidase A-catalyzed degradation of ganglioside GM2 and glycolipid GA2.
    Conzelmann E; Sandhoff K
    Proc Natl Acad Sci U S A; 1978 Aug; 75(8):3979-83. PubMed ID: 99746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical basis of type AB GM2 gangliosidosis in a Japanese spaniel.
    Ishikawa Y; Li SC; Wood PA; Li YT
    J Neurochem; 1987 Mar; 48(3):860-4. PubMed ID: 2949061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.